127 related articles for article (PubMed ID: 15039627)
1. [Retinopathy caused by interferon alpha associated with ribavirin therapy and the importance of the electro-oculogram: a case report].
Crochet M; Ingster-Moati I; Even G; Dupuy P
J Fr Ophtalmol; 2004 Mar; 27(3):257-62. PubMed ID: 15039627
[TBL] [Abstract][Full Text] [Related]
2. Is screening for interferon retinopathy in hepatitis C justified?
Cuthbertson FM; Davies M; McKibbin M
Br J Ophthalmol; 2004 Dec; 88(12):1518-20. PubMed ID: 15548803
[TBL] [Abstract][Full Text] [Related]
3. [Reversible Perimacular Retinopathy by Long-Time Interferon alpha Therapy].
Sandner D; Pillunat LE
Klin Monbl Augenheilkd; 2004 Jan; 221(1):63-6. PubMed ID: 14745683
[TBL] [Abstract][Full Text] [Related]
4. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
Schulman JA; Liang C; Kooragayala LM; King J
Ophthalmology; 2003 Feb; 110(2):437-42. PubMed ID: 12578794
[TBL] [Abstract][Full Text] [Related]
5. [Retinopathy in a patient with hepatitis C treated with pegylated interferon and ribavirin: case report].
Avila MP; Freitas AM; Isaac DL; Bastos AL; Pena RV
Arq Bras Oftalmol; 2006; 69(2):255-9. PubMed ID: 16699680
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C.
Okuse C; Yotsuyanagi H; Nagase Y; Kobayashi Y; Yasuda K; Koike K; Iino S; Suzuki M; Itoh F
World J Gastroenterol; 2006 Jun; 12(23):3756-9. PubMed ID: 16773695
[TBL] [Abstract][Full Text] [Related]
7. [Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C].
Nakamura T; Takahashi H; Koike N; Mitsutaka M; Soda M; Kimu M
Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):748-52. PubMed ID: 16363669
[TBL] [Abstract][Full Text] [Related]
8. Retinopathy in chronic hepatitis C patients during interferon treatment: a case report.
Rossi C; Scotton PG; Farina F; Vaglia A
Infez Med; 2010 Dec; 18(4):267-9. PubMed ID: 21196822
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
[TBL] [Abstract][Full Text] [Related]
10. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
Burgueño-Montañés C; Pérez-Álvarez R
Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin.
Novelli FJ; Przysiezny A; Rosa EL; Garcia RF; Nóbrega MJ
Arq Bras Oftalmol; 2014; 77(3):178-81. PubMed ID: 25295906
[TBL] [Abstract][Full Text] [Related]
12. Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C.
Moisseiev E; Goldenberg D; Kurtz S
Ophthalmic Surg Lasers Imaging; 2011 Sep; 42 Online():e91-3. PubMed ID: 21899250
[TBL] [Abstract][Full Text] [Related]
13. [Ocular complications of hepatitis C treatment].
Sauer A; Lenoble P; Bader P; Speeg-Schatz C; Bourcier T; Nasica X
J Fr Ophtalmol; 2007 Sep; 30(7):e20. PubMed ID: 17878818
[TBL] [Abstract][Full Text] [Related]
14. Retinal nerve fibre layer defects associated with cotton-wool spots in patients with interferon retinopathy.
Hara K; Tanito M; Ohira A
Acta Ophthalmol; 2012 Mar; 90(2):e158-60. PubMed ID: 21649866
[No Abstract] [Full Text] [Related]
15. Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study.
Lai CH; Yang YH; Chen PC; King YC; Liu CY
Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):191-198. PubMed ID: 29210149
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment.
Tsolakos A; Zalatimo N
Optometry; 2003 Aug; 74(8):517-23. PubMed ID: 12926825
[TBL] [Abstract][Full Text] [Related]
17. Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C.
Adams S; Ostermeier M
Optometry; 2010 Nov; 81(11):580-6. PubMed ID: 20655283
[TBL] [Abstract][Full Text] [Related]
18. [Interferon-related retinopathy in a man with chronic hepatitis C].
Viennet A; Glatre F; Bacin F
J Fr Ophtalmol; 2009 Sep; 32(7):505-10. PubMed ID: 19592135
[TBL] [Abstract][Full Text] [Related]
19. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
[TBL] [Abstract][Full Text] [Related]
20. EOG as a monitor of desferrioxamine retinal toxicity.
Hidajat RR; McLay JL; Goode DH; Spearing RL
Doc Ophthalmol; 2004 Nov; 109(3):273-8. PubMed ID: 15957612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
